Results of a new study find that a drug from Merck called Proscar, which is used to control a man’s enlarged prostate, does not increase the risk of hip fractures.

Many men living in the US exhibit symptoms of an enlarged prostate, ranging from difficulty urinating, to the constant need to urinate.

Furthermore, the study of men over the age of 45, showed that the drug appears to make their bones even stronger and not weaker, as was originally believed to be the case.

For their study researchers used data from Kaiser Permanente Southern California, a managed care organization with more than 3 million members.

The researchers compared hip fracture numbers spanning the time between 1997 and 2006, along with seeing who was taking Proscar and who was not.

There was no noted difference between the men who took the drug and those who did not when it came to rate of hip fractures.

Men who took Proscar had more than a 20% reduced risk of having a hip fracture when compared with those men who did not take the drug.

The study can be found in the Journal of the American Medical Association.